# Decheng Capital LLC: Form 13F holdings

An institutional investment manager in MENLO PARK, CA. SEC CIK 2010850.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $731.7m
- Positions: 14 (14 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/2010850/000110465926096837/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [CG ONCOLOGY INC (CGON)](/companies/cgon.md) | COM | $452.7m | 61.9% | 6,371,669 |  | Unchanged |
| [Nuvation Bio Inc. (NUVB)](/companies/nuvb.md) | COM | $147.4m | 20.1% | 25,954,439 |  | Unchanged |
| [AARDVARK THERAPEUTICS INC (AARD)](/companies/aard.md) | COM | $22.6m | 3.1% | 3,917,299 |  | Unchanged |
| [Aclaris Therapeutics, Inc. (ACRS)](/companies/acrs.md) | COM | $21.4m | 2.9% | 4,041,736 |  | Unchanged |
| [Upstream Bio Inc. (UPB)](/companies/upb.md) | COM | $18.9m | 2.6% | 2,724,868 |  | Unchanged |
| [Arcus Biosciences, Inc (RCUS)](/companies/rcus.md) | COM | $14.3m | 2.0% | 464,779 |  | Reduced −13,040 |
| [Equillium Inc. (EQ)](/companies/eq.md) | COM | $14.2m | 1.9% | 4,447,308 |  | Unchanged |
| [REVOLUTION MEDICINES INC(NSM) (RVMD)](/companies/rvmd.md) | COM | $9.9m | 1.3% | 52,667 |  | Reduced −40,833 |
| Lyell Immunopharma, Inc. | COM | $9.7m | 1.3% | 692,050 |  | Unchanged |
| BeyondSpring Inc. | SHS | $6.7m | 0.9% | 3,800,702 |  | Unchanged |
| [Zentalis Pharmaceuticals Inc. (ZNTL)](/companies/zntl.md) | COM | $6.4m | 0.9% | 1,323,327 |  | Unchanged |
| NEWAMSTERDAM PHARMA CO NV | COM | $6.0m | 0.8% | 176,887 |  | Reduced −148,170 |
| [Pyxis Oncology, Inc (formerly Apexigen) (PYXS)](/companies/pyxs.md) | COM | $983.7k | 0.1% | 326,810 |  | Unchanged |
| [TANGO THERAPEUTICS INC (TNGX)](/companies/tngx.md) | COM | $625.2k | <0.1% | 20,000 |  | New +20,000 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [KRYSTAL BIOTECH INC (KRYS)](/companies/krys.md) | COM | $0 | 0.0% | 0 |  | Sold out −7,300 |

Source: SEC EDGAR, Form 13F-HR, accession 0001104659-26-096837. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.